Bacterial resistance to antibiotics kills between 1.25-5 million people every year. So why is antimicrobial resistance (AMR) not given the priority or funding that some other health problems receive?
We hear from Christopher Murray, director of the Institute for Health Metrics and Evaluation which has done the first global assessment of the impact of AMR, and UK AMR envoy Sally Davies, who says AMR needs to be treated as a pandemic.
